↓ Skip to main content

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
65 Mendeley